MAT2A and breast cancer: The results showed that the antibody of METTL16 enriched the FBXO5 mRNA (Fig. 3F) and MAT2A mRNA (Supplementary Fig. 1) in BC cells, indicated the binding relationship between METTL16 and FBXO5 mRNA.